emerg
porcin
epidem
diarrhea
virus
pedv
caus
larg
econom
loss
sinc
preval
global
epidem
genotyp
given
fastidi
isol
emerg
pedv
cell
cultur
difficulti
retain
isol
infect
upon
vitro
passag
highli
attenu
recombin
vesicular
stomat
viru
rvsv
mt
use
vector
express
pedv
spike
protein
aim
develop
subunit
vaccin
virus
protein
cytoplasm
domain
amino
acid
delet
could
incorpor
vsv
particl
gener
rvsv
mt
vsv
mt
high
effici
result
suggest
vsv
mt
could
effect
induc
pedvspecif
immun
pig
via
intramuscular
intranas
immun
notabl
immun
sow
vsv
mt
provid
protect
lactogen
immun
virul
pedv
challeng
piglet
consequ
recombin
vsv
mt
may
promis
platform
prepar
subunit
vaccin
pedv
porcin
epidem
diarrhea
viru
pedv
coronaviru
initi
identifi
pensaert
de
bouck
endem
mainli
asia
pedv
outbreak
emerg
china
spread
countri
asia
north
america
vlasova
et
al
pedv
genom
consist
singlestrand
positivesens
rna
molecul
structur
protein
includ
spike
membran
envelop
e
nucleocapsid
n
protein
protein
respons
viru
attach
receptor
bind
cell
membran
fusion
entri
induc
neutral
antibodi
host
lai
et
al
phylogenet
analysi
base
gene
align
indic
pedv
categor
two
genotyp
genotyp
genotyp
genotyp
consist
two
subgroup
isol
usual
pathogen
lee
pedv
includ
classic
strain
isol
found
asia
notabl
isol
respons
recent
pandem
outbreak
north
america
asia
character
high
mortal
piglet
huang
et
al
vlasova
et
al
wang
et
al
although
inactiv
attenu
vaccin
base
classic
strain
wide
use
china
porcin
epidem
diarrhea
ped
still
control
effect
wang
et
al
lowtomoder
effect
current
vaccin
may
attribut
antigen
differ
protein
vaccin
field
epizoot
strain
lee
current
commerci
vaccin
strain
remain
unavail
isol
pedv
cell
cultur
proven
fastidi
success
isol
viru
may
still
incap
retain
infect
upon
vitro
passag
hofmann
wyler
oka
et
al
laboratori
hurdl
make
product
efficaci
vaccin
challeng
pedv
protein
truncat
version
express
recombin
viral
vector
shown
potenti
use
develop
subunit
vaccin
pedv
hain
et
al
yuan
et
al
vesicular
stomat
viru
vsv
promis
viral
vector
express
foreign
antigen
capabl
potent
stimul
host
humor
cellular
immun
respons
robert
et
al
tan
et
al
present
studi
highli
attenu
recombin
vsv
tripl
amino
acid
mutat
protein
vsv
mt
use
express
protein
pedv
aim
develop
mucos
vaccin
predomin
epidem
isol
fang
et
al
data
indic
amino
acid
cytoplasm
domain
delet
protein
could
effici
incorpor
vsv
particl
lead
gener
recombin
vsv
vsv
mt
high
effici
vivo
studi
reveal
vsv
mt
could
effect
induc
antipedv
immun
pig
via
intramuscular
intranas
immun
notabl
administr
vsv
mt
sow
stimul
robust
passiv
immun
neonat
piglet
could
resist
lethaldos
challeng
virul
homolog
pedv
strain
thu
togeth
advantag
vsv
mt
replic
cell
titer
pfuml
cell
grow
suspens
dispos
bioreactor
cell
concentr
higher
cellsml
find
indic
recombin
vsv
mt
could
promis
platform
rapidli
develop
vaccin
emerg
reemerg
epidem
strain
pedv
babi
hamster
kidney
cell
atcc
african
green
monkey
cell
vero
atcc
grown
dmem
medium
supplement
fetal
bovin
serum
gibco
usa
cell
cultur
humidifi
air
contain
co
vsv
mt
pedv
prepar
previous
describ
fang
et
al
hofmann
wyler
vsv
pedv
convalesc
sera
prepar
infect
mice
pig
respect
sh
sh
two
emerg
pedv
strain
isol
respect
shanghai
china
genom
sequenc
submit
genbank
genbank
no
gene
two
strain
align
prototyp
pedv
strain
repres
emerg
pedv
strain
includ
ah
refer
number
corolado
refer
number
ussindel
strain
refer
number
supl
tabl
phylogenet
tree
pedv
strain
construct
use
neighborjoin
nj
method
mega
phylogenet
tree
root
outgroup
tgev
strain
access
number
bootstrap
resampl
replic
perform
indic
node
scale
bar
result
tree
indic
nucleotid
substitut
per
site
cytoplasm
tail
ct
pedv
compos
amino
acid
construct
vsv
mt
express
fulllength
fl
truncat
protein
vsv
mt
sequenti
delet
ct
within
protein
gene
first
perform
amino
acid
aa
pcr
primer
use
amplifi
gene
mutant
shown
tabl
mutat
gene
insert
clone
site
g
l
gene
vsv
genom
use
one
step
seamless
clone
kit
yeasen
china
xhoi
nhei
restrict
enzym
digest
result
plasmid
design
pvsv
mt
recoveri
vsv
mt
viru
perform
follow
method
fang
et
al
briefli
cell
infect
h
recombin
vaccinia
viru
express
rna
polymeras
infect
cell
cotransfect
pvsv
mt
clone
contain
fulllength
gene
one
truncat
version
togeth
helper
plasmid
pbsn
p
l
h
transfect
cultur
supernat
collect
filter
fresh
cell
membran
cell
check
daili
infect
typic
cytopath
effect
observ
day
afterward
supernat
collect
virus
plaquepurifi
vero
cell
individu
plaqu
isol
seed
stock
amplifi
cell
rescu
virus
initi
confirm
rtpcr
viral
stock
amplifi
passag
multipl
infect
moi
cell
purifi
recombin
vsv
cell
cultur
fluid
clarifi
centrifug
rmin
min
virus
concentr
via
centrifug
wv
sucros
cushion
h
rotor
beckman
usa
pellet
resuspend
tnc
buffer
trishcl
nacl
mm
cacl
ph
virion
purifi
wv
sucros
gradient
ultracentrifug
h
rotor
beckman
final
pellet
resuspend
tnc
buffer
purifi
virus
analyz
western
blot
typic
band
vsv
pedv
detect
use
convalesc
sera
vsvinfect
mice
pedvinfect
pig
character
replic
kinet
vsv
mt
vitro
onestep
growth
curv
set
cell
briefli
cell
plate
infect
vsv
mt
vsv
mt
moi
h
absorpt
inoculum
remov
cell
wash
three
time
dpb
fresh
dmem
supplement
fetal
bovin
serum
ad
infect
cell
incub
aliquot
cell
cultur
supernat
remov
triplic
h
postinocul
hpi
viral
titer
cellular
supernat
detect
plaqu
assay
describ
mean
valu
quantifi
vsvbase
vaccin
proven
capabl
induc
gut
mucos
immun
mice
via
intranas
rout
wu
et
al
identifi
immunogen
vsv
mt
vivo
mice
pig
inocul
viru
via
intramuscular
im
rout
anim
experi
conduct
accord
ethic
guidelin
shanghai
jiao
tong
univers
specificpathogen
free
spf
femal
balbc
mice
g
bodi
tabl
pcr
primer
amplifi
pedv
gene
differ
length
cytoplasm
tail
sequenc
forward
primer
xhoi
site
shown
red
revers
primer
nhei
site
shown
red
ke
et
al
virolog
weight
purchas
shanghai
slac
experiment
anim
compani
chines
academi
scienc
china
shown
tabl
mice
randomli
divid
five
group
five
anim
highdos
live
vsv
mt
lowdos
live
vsv
mt
im
highdos
binari
ethylenimin
bei
inactiv
vsv
mt
im
lowdos
beiinactiv
vsv
mt
pb
mockvaccin
group
anim
prime
day
boost
day
later
inactiv
virus
bei
perform
describ
previous
bahnemann
im
group
beiinactiv
vsv
mt
mix
freund
complet
adjuv
sigma
usa
prime
freund
incomplet
adjuv
booster
immun
blood
sampl
collect
day
everi
day
day
postvaccin
anim
sera
separ
store
use
neutral
assay
pig
experi
experi
immunogen
assess
pig
pig
vaccin
vsv
mt
via
im
rout
total
healthi
bama
minipig
purchas
swine
centr
univers
shanghai
jiao
tong
univers
anim
neg
vsv
pedv
base
serum
neutral
antibodi
assay
prior
studi
randomli
divid
five
group
three
anim
highdos
live
vsv
mt
lowdos
live
vsv
mt
im
beiinactiv
highdos
vsv
mt
im
beiinactiv
lowdos
vsv
mt
pb
mock
vaccin
group
tabl
im
group
beiinactiv
vsv
mt
also
mix
freund
complet
adjuv
sigma
prime
freund
incomplet
adjuv
booster
immun
blood
sampl
collect
day
everi
day
day
postvaccin
anim
sera
separ
store
use
addit
assay
tabl
vsv
mt
mix
adjuv
follow
manufactur
protocol
pig
inocul
twice
separ
interv
via
im
rout
two
side
neck
pig
blood
collect
primari
inocul
everi
day
day
postvaccin
blood
sampl
collect
pig
anterior
vena
cava
serum
separ
store
experi
sow
immun
piglet
challeng
test
lactogen
immun
transfer
pregnant
sow
neonat
piglet
three
healthi
pregnant
bama
sow
bodi
weight
kg
intramuscularli
vaccin
three
time
day
apart
day
sow
farrow
dose
experiment
vaccin
contain
pfu
beiinactiv
vsv
mt
emulsifi
suitabl
adjuv
three
sow
inocul
pb
set
mock
control
farrow
induc
day
last
vaccin
blood
sampl
collect
sow
prior
vaccin
farrow
colostrum
sampl
collect
day
sow
farrow
piglet
allow
suckl
dam
day
birth
litter
vsv
mt
mock
vaccin
group
oral
challeng
virul
isol
dose
tcid
addit
two
piglet
randomli
select
litter
mockvaccin
sow
inocul
oral
pb
mock
challeng
control
clinic
sign
diarrhea
moral
weight
challeng
piglet
monitor
daili
throughout
studi
rectal
swab
collect
daili
piglet
detect
presenc
viral
rna
rtqpcr
previous
describ
makadiya
et
al
blood
sampl
collect
piglet
day
challeng
use
viru
neutral
vn
antibodi
assay
anim
monitor
clinic
sign
day
postchalleng
clinic
signific
score
css
determin
previous
describ
makadiya
et
al
use
follow
score
criteria
measur
diarrhea
sever
normal
diarrhea
mean
ct
valu
mild
fluidic
fece
moder
wateri
diarrhea
sever
wateri
projectil
diarrhea
mean
ct
valu
death
sera
experiment
anim
heatinactiv
min
prior
antibodi
detect
pedvspecif
neutral
antibodi
sera
detect
use
vn
assay
microtit
plate
previous
describ
makadiya
et
al
vsvspecif
neutral
antibodi
anim
serum
determin
previous
describ
fang
et
al
colostrum
milk
sow
collect
incub
rennin
final
concentr
min
solidifi
whey
separ
centrifug
rpm
min
whey
collect
kept
test
presenc
pedvor
vsvspecif
neutral
antibodi
whey
also
determin
use
vn
assay
previous
describ
makadiya
et
al
pedvspecif
igg
pig
serum
detect
elisa
kit
manufactur
nation
engin
research
centr
veterinari
biolog
corp
harbin
china
briefli
serum
sampl
ad
plate
coat
pedv
duplic
incub
h
plate
wash
three
time
pb
tween
hrpconjug
antipig
igg
ad
well
plate
incub
h
anoth
round
wash
color
develop
carri
ad
tmb
substrat
well
incub
plate
min
addit
stop
solut
absorb
measur
nm
sp
valu
calcul
follow
test
sampl
valu
neg
control
valu
posit
control
valu
neg
control
valu
sp
valu
defin
posit
statist
analys
perform
use
spss
softwar
chicago
usa
exact
test
vari
depend
type
experi
differ
two
group
assess
use
unpair
twotail
ttest
statist
analys
among
multipl
group
varianc
conduct
use
oneway
anova
signific
differ
mean
determin
use
duncan
multipl
rang
test
pvalu
consid
statist
signific
phylogenet
analysi
indic
epidem
pedv
strain
belong
genotyp
gene
use
construct
vsvbase
pedv
vaccin
current
four
pedv
subtyp
endem
pig
farm
china
includ
vaccin
strain
new
variant
past
epidem
strain
current
domin
epidem
strain
lee
given
issu
epidem
relat
strain
circul
field
employ
develop
next
gener
vaccin
howev
commerci
vaccin
strain
still
unavail
virul
pedv
isol
collect
shanghai
china
strain
caus
morbid
mortal
suckl
piglet
studi
phylogenet
analysi
base
pedv
gene
indic
map
fig
close
relat
ah
regard
origin
pedv
outbreak
usa
canada
huang
et
al
howev
long
genet
distanc
prototyp
identifi
belong
genotyp
fig
least
four
neutral
domain
pedv
protein
ntermin
domain
ntd
region
li
et
al
coe
domain
residu
chang
et
al
region
residu
span
junction
region
sun
et
al
epitop
protein
cterminu
residu
cruz
et
al
align
fulllength
protein
amino
acid
sequenc
indic
similar
corolado
supl
fig
major
differ
among
variou
strain
exist
within
region
particularli
ntd
domain
similar
amino
acid
sequenc
among
sh
ah
us
repres
strain
colorado
could
reach
wherea
similar
typic
aa
insert
two
site
aa
delet
site
protein
strain
sh
ah
corolado
contrast
supl
fig
total
mutat
exist
coe
region
compar
three
locat
eight
coe
domain
ctermin
epitop
highli
conserv
epitop
surprisingli
differ
identifi
among
strain
includ
studi
observ
differ
especi
within
neutral
epitop
may
contribut
current
vaccin
failur
field
thu
given
high
similar
protein
predomin
pedv
strain
use
construct
vsvbase
pedv
subunit
vaccin
close
related
predomin
isol
china
countri
chose
protein
use
vaccin
develop
initi
construct
rvsv
plasmid
fulllength
pedv
gene
howev
replicationcompet
rvsv
rescu
next
gener
rvsv
plasmid
encod
cterminaltrunc
version
protein
delet
aa
fig
b
howev
result
plasmid
pvsv
mt
encod
fulllength
pedv
protein
except
ctermin
amino
acid
found
capabl
rescu
rvsv
result
viru
caus
typic
cytopath
effect
freshli
prepar
cell
name
vsv
mt
confirm
recoveri
vsv
mt
rna
extract
plaquepurifi
rvsv
clone
rtpcr
assay
perform
amplifi
gene
identifi
via
dna
sequenc
data
shown
confirm
protein
inde
express
incorpor
vsv
particl
vsv
mt
purifi
ultracentrifug
analyz
western
blot
use
convalesc
sera
pedvinfect
pig
primari
antibodi
kda
pedv
protein
detect
purifi
vsv
mt
vsv
mt
posit
control
pedv
strain
addit
protein
kda
n
protein
kda
also
detect
fig
use
convalesc
sera
vsvinfect
mous
primari
antibodi
typic
band
vsv
structur
protein
l
g
np
well
detect
previous
report
robert
et
al
vsv
mt
vsv
mt
mock
control
fig
result
indic
vsv
mt
success
rescu
pedv
protein
incorpor
effici
vsv
particl
character
replic
kinet
vsv
mt
vitro
onestep
growth
curv
viru
set
cell
moi
vsv
mt
control
shown
fig
titer
supernat
vsv
mt
inocul
cell
increas
postinocul
titer
reach
peak
pfuml
hpi
declin
vsv
mt
also
reach
highest
titer
pfu
ml
hpi
togeth
result
show
vsv
mt
could
replic
effici
vitro
level
compar
vsv
mt
explor
pedvspecif
immunogen
vsv
mt
vivo
mice
pig
inocul
viru
im
rout
pb
mock
vaccin
control
shown
fig
virusspecif
antibodi
detect
control
mice
pig
howev
emulsifi
freund
adjuv
vsv
mt
could
induc
pedvand
vsvspecif
immun
via
im
rout
pig
mice
doseand
timedepend
manner
im
highdos
mous
group
pedvspecif
vn
titer
peak
day
second
immun
wherea
vsvspecif
vn
titer
fig
notabl
although
pedvspecif
vn
antibodi
could
induc
via
rout
either
high
lowdos
live
vsv
mt
mice
vsvspecif
vn
antibodi
could
still
detect
inocul
mice
peak
titer
highdos
group
day
postboost
vaccin
fig
humor
immun
respons
elicit
vsv
mt
pig
examin
elisa
neutral
assay
pig
vaccin
via
im
rout
show
increas
vn
antibodi
titer
serum
igg
level
first
second
vaccin
highdos
group
pedvspecif
vn
antibodi
titer
peak
day
second
immun
wherea
vsvspecif
vn
antibodi
titer
peak
fig
similarli
serum
igg
level
reach
peak
day
second
immun
im
highdos
pig
group
mice
vsvspecif
pedvspecif
antibodi
could
detect
pig
immun
vsv
mt
via
rout
fig
togeth
find
indic
vsv
mt
could
simultan
stimul
pedvand
vsvspecif
humor
immun
respons
pig
mice
via
im
rout
although
freund
adjuv
commonli
use
research
prohibit
use
farm
industri
toxic
formul
clinic
useabl
vaccin
vsv
mt
follow
three
commerci
adjuv
test
im
vg
npr
adjuv
im
isa
vg
adjuv
isa
vg
adjuv
nanoparticl
adjuv
wateroilwat
emuls
oilwat
emuls
purifi
vsv
mt
separ
mix
adjuv
pig
intramuscularli
inocul
twice
day
apart
day
dose
pfu
shown
fig
pedvand
vsvspecif
neutral
antibodi
effect
stimul
pig
first
immun
pedvspecif
vn
titer
group
respect
wherea
group
reach
pedvspecif
vn
titer
group
eventu
peak
day
second
immun
declin
rapidli
contrast
pedvspecif
vn
titer
group
reach
maintain
level
day
second
immun
sera
igg
level
pig
vaccin
vsv
mt
emulsifi
posit
day
first
immun
sp
valu
significantli
higher
adjuv
p
fig
addit
advers
reaction
observ
inject
site
use
adjuv
wherea
advers
effect
skin
occur
pig
use
adjuv
data
shown
togeth
result
indic
suitabl
use
adjuv
futur
studi
vaccin
sinc
mani
emerg
pedv
isol
character
high
mortal
piglet
assess
piglet
passiv
immun
pedv
transfer
immun
sow
vsv
mt
emulsifi
inject
pregnant
sow
three
time
pfu
dose
via
im
rout
pb
mock
control
humor
immun
respons
sow
elicit
vsv
mt
examin
neutral
assay
serum
colostrummilk
vaccin
sow
show
increas
specif
serum
neutral
antibodi
titer
vaccin
peak
second
immun
maintain
level
day
farrow
fig
vn
titer
whey
colostrum
milk
also
peak
first
fifth
day
postfarrow
level
significantli
higher
vn
titer
control
sow
p
fig
sera
collect
piglet
litter
vaccin
sow
day
birth
day
pedv
challeng
vn
titer
level
also
significantli
higher
compar
litter
control
sow
p
fig
test
protect
potenti
immun
transfer
vsv
mt
vaccin
sow
piglet
deliv
vaccin
mockvaccin
sow
oral
challeng
virul
sh
addit
six
piglet
mockvaccin
sow
also
inocul
pb
fig
phylogenet
analysi
emerg
pedv
isol
base
gene
phylogenet
tree
includ
classic
strain
global
emerg
strain
epidem
strain
china
construct
use
mega
neighborjoin
nj
method
bootstrap
resampl
replic
perform
bootstrap
valu
indic
node
tgev
strain
access
number
set
outgroup
mockchalleng
control
piglet
monitor
daili
day
postchalleng
dpc
clinic
symptom
fecal
grade
bodi
weight
mortal
pedv
rna
extract
daili
rectal
swab
piglet
assess
rtqpcr
shown
fig
follow
challeng
sh
bodi
weight
piglet
mockvaccin
sow
drop
dpc
level
significantli
lower
two
group
p
fig
sever
wateri
diarrhea
vomit
could
observ
anim
clinic
score
reach
high
viru
shed
fece
confirm
rtqpcr
ct
valu
reach
low
dpc
remain
less
dpc
level
also
significantli
lower
two
group
fig
p
piglet
deliv
mockvaccin
sow
die
virul
pedv
challeng
fig
contrast
piglet
deliv
vsv
mt
vaccin
sow
surviv
virul
pedv
challeng
bodi
weight
start
increas
dpc
fig
surprisingli
wateri
diarrhea
observ
mockchalleng
piglet
averag
clinic
score
less
ct
valu
challeng
piglet
vaccin
sow
mild
diarrhea
begin
dpc
clinic
score
around
howev
dpc
wateri
diarrhea
observ
anim
fig
addit
reduc
viru
shed
observ
piglet
vaccin
sow
follow
oral
challeng
mean
ct
valu
increas
dpc
fig
togeth
result
indic
exposur
sow
vsv
mt
could
provid
protect
lactogen
immun
piglet
challeng
homolog
virul
pedv
vaccin
fundament
strategi
control
erad
ped
howev
crossprotect
pedv
genotyp
incomplet
gerdt
zakhartchouk
tradit
vaccin
base
classic
genotyp
strain
effect
control
epidem
emerg
isol
predominantli
belong
subtyp
asia
america
lee
wang
et
al
current
commerci
vaccin
epidem
still
unavail
therefor
strainbas
vaccin
develop
virul
pedv
strain
isol
shanghai
china
high
mortal
almost
infect
neonat
piglet
caus
seriou
clinic
diseas
symptom
wateri
diarrhea
nurs
pig
sow
antigen
analysi
show
major
differ
among
variou
genotyp
pedv
strain
mainli
locat
within
region
especi
within
ntd
domain
phylogenet
analysi
base
gene
indic
map
subtyp
addit
analysi
protein
amino
acid
sequenc
confirm
close
relationship
emerg
strain
pedv
includ
ah
consid
origin
pedv
strain
caus
largescal
outbreak
usa
sinc
huang
et
al
base
find
select
candid
use
make
novel
pedv
vaccin
present
one
major
hurdl
pedv
vaccin
develop
isol
pedv
cell
cultur
proven
fastidi
timeconsum
isol
viru
may
still
incap
retain
infect
upon
vitro
passag
issu
gerdt
et
al
claim
research
nextgener
vaccin
subunit
viralvector
approach
critic
prevent
futur
outbreak
emerg
coronaviru
diseas
gerdt
zakhartchouk
hain
et
al
develop
recombin
parapoxviru
vector
express
protein
hain
et
al
recombin
vsv
promis
vaccin
vector
express
foreign
antigen
use
platform
construct
human
vaccin
wellknown
vsvbase
ebola
viru
vaccin
regul
et
al
shown
cytoplasm
tail
coroanviru
spike
protein
play
key
role
incorpor
vsv
particl
schwegmannwessel
et
al
studi
fulllength
gene
initi
clone
genom
highli
attenu
vsv
mt
aim
make
mucos
vaccin
base
replicationcompet
vsv
pig
howev
rvsv
mt
fl
recoveri
observ
pedv
tgev
belong
alphacoronaviru
genu
within
coronavirida
famili
tyrosinebas
motif
yxxi
within
cytoplasm
tail
tgev
spike
protein
lead
intracellular
retent
thu
interfer
incorpor
vsv
particl
schwegmannwessel
et
al
delet
yxxi
motif
result
success
recoveri
recombin
vsv
pseudotyp
truncat
tgev
schwegmannwessel
et
al
noteworthi
conserv
dibas
motif
kxhxx
within
pedv
cytoplasm
tail
kvhvq
also
lead
retent
protein
endoplasm
reticulumgolgi
intermedi
compart
ergic
http
wwwncbinlmnihgovpubm
termshirato
cauthortru
shirato
et
al
shown
hou
et
al
yxxi
kxhxx
motif
within
pedv
tail
synergist
regul
express
cell
surfac
hou
et
al
consequ
tgev
failur
fulllength
pedv
incorpor
vsv
particl
might
also
due
intracellular
retent
rather
presenc
plasma
membran
vsv
assembl
bud
process
remov
yxxi
kxhxx
motif
gener
rvsv
mt
plasmid
express
mutant
aa
cytoplasm
domain
delet
fig
b
result
plasmid
pvsv
mt
encod
except
ctermin
amino
acid
achiev
success
rescu
wherea
construct
fail
result
suggest
structur
featur
within
truncat
protein
optim
length
truncat
cytoplasm
tail
might
also
essenti
incorpor
vsv
particl
even
though
intracellular
retent
signal
remov
howev
detail
mechan
still
need
clarif
futur
studi
notabl
although
insert
larges
foreign
protein
vsv
mt
still
could
replic
effici
parent
viru
vsv
mt
vitro
maximum
titer
data
present
mean
sd
statist
analys
conduct
use
oneway
anova
signific
differ
mean
determin
use
duncan
multipl
rang
test
statist
signific
level
mean
vg
group
compar
mean
vg
vg
group
fig
pedvspecif
humor
respons
sow
piglet
pregnant
sow
vaccin
vsv
mt
pb
three
time
day
indic
arrow
pedvspecif
viru
neutral
vn
antibodi
titer
sera
sow
collect
indic
time
point
postinocul
b
vn
antibodi
titer
whey
colostrum
milk
collect
sow
indic
timepoint
c
vn
antibodi
titer
sera
collect
piglet
suckl
vaccin
control
sow
milk
day
virul
pedv
challeng
statist
analys
perform
use
unpair
twotail
ttest
data
present
mean
sd
p
p
exceed
pfuml
cell
togeth
advantag
cell
grow
suspens
dispos
bioreactor
cell
concentr
higher
cellsml
genzel
recombin
vsv
could
ideal
platform
conveni
prepar
vaccin
emerg
reemerg
pedv
present
still
difficult
construct
recombin
pedv
use
revers
genet
howev
help
vsvbase
pedv
protein
epitop
especi
conform
epitop
protein
might
map
accur
even
level
singl
amino
acid
addit
role
protein
loss
crossprotect
genotyp
isol
might
also
identifi
techniqu
foreign
antigen
deliv
live
vsv
vector
via
rout
immun
shown
capabl
induc
mucos
immun
enterovirus
like
enteroviru
coxsackieviru
mice
wu
et
al
howev
induct
mucos
immun
manner
yet
confirm
natur
host
vsv
pig
hypothes
vsv
mt
could
also
stimul
pedvspecif
gut
immun
pig
administ
via
rout
observ
robust
vsvspecif
humor
immun
respons
follow
immun
suggest
administ
vsv
mt
replic
nasal
mucosa
howev
surpris
pedvspecif
humor
respons
could
detect
reason
failur
vsv
mt
stimul
pedvspecif
antibodi
administ
via
rout
still
need
clarif
possibl
protein
express
tissu
cell
success
present
host
antigenpres
cell
thu
fail
stimul
product
pedvspecif
antibodi
similar
result
found
recombin
parapox
virusbas
pedv
vaccin
report
stimul
pedvspecif
immun
administ
via
im
rout
transcutan
rout
natur
infect
rout
parapox
viru
hain
et
al
addit
demonstr
pedvspecif
immun
respons
could
stimul
effect
sow
immun
via
im
rout
vsv
mt
express
pedv
protein
notabl
among
adjuv
test
present
studi
nanoparticl
adjuv
potent
formul
vsvbase
pedv
vaccin
neutral
antibodi
titer
well
serum
igg
pedv
posit
detect
earli
day
postprimari
immun
furthermor
passiv
transfer
antibodi
immun
sow
piglet
observ
pedvspecif
neutral
antibodi
detect
serum
piglet
born
immun
sow
follow
ingest
colostrum
milk
summari
studi
show
pedv
protein
aa
within
carboxyl
termin
delet
could
express
incorpor
vsv
mt
particl
effici
addit
vsvbase
pedv
subunit
vaccin
could
confer
potent
passiv
immun
pedv
piglet
follow
immun
pregnant
sow
protect
efficaci
piglet
passiv
immun
sow
vaccin
litter
vsv
mt
vaccin
mockvaccin
sow
oral
challeng
virul
pedv
day
age
mockchalleng
control
oral
inocul
pb
born
mockvaccin
sow
clinic
signific
score
determin
describ
materi
method
piglet
bodi
weight
chang
b
surviv
rate
piglet
c
piglet
fecal
score
viru
shed
pedv
viral
rna
extract
rectal
swab
challeng
mockchalleng
piglet
assess
realtim
rtpcr
valu
mean
standard
deviat
statist
analys
among
multipl
group
varianc
conduct
use
oneway
anova
signific
differ
mean
determin
use
duncan
multipl
rang
test
p
p
mean
mock
vaccin
challeng
group
compar
mean
mock
challeng
vaccin
challeng
group
